NH Foods Ltd.2282.T
Pull the consolidated 4.7% business-profit margin apart and the thing underneath is barely one company: a Fresh Meats spread engine earning roughly 6% that carries nine-tenths of group profit, a Processed arm stuck near 1.4%, and a baseball stadium — ES CON FIELD — quietly earning 19.5%. The number everyone is arguing about, +60.7% business profit in FY March 2026, is almost entirely that spread, and management already guides it lower. Valued part by part, the sum lands within a few percent of the price. What is left to settle is narrower: whether the protein peak is a plateau or a top, and whether the dormant ballpark and an active buyback are worth more than a single food multiple admits.
Fresh Meats, at ¥68bn of normalised EBITDA on the 7.5x its vertical integration and 20%-plus domestic share earn, is worth roughly ¥510bn — three-quarters of the operating value, and effectively the whole company.
Processed Foods adds ¥156bn at a 6.5x multiple discounted for its loss-making overseas plants ; the ES CON FIELD ballpark adds ¥64bn, the entertainment franchise capitalised at a 7% rate ; corporate cost removes ¥38bn. Operating enterprise value reconstructs to ¥692bn.
Non-operating assets of ¥45bn, less net debt of ¥160bn, pension and minorities, bring equity to ¥550.6bn — ¥5,849 a share on the 94.1m net-of-treasury count. Triangulated against a normalised P/E and a re-rating P/B, the base settles at ¥6,100.
The market capitalises NH Foods at ¥570.8bn. The deep-value discount the inherited thesis was built on is mostly closed.
The interesting thing about NH Foods is that the headline jump is real and almost entirely beside the point. Group business profit rose 60.7% in FY March 2026, to ¥68.3bn, and on a quick read that looks like a company stepping up to a new level of earnings. It is not. About nine-tenths of the increase came from one segment, Fresh Meats, on a widening protein spread — cheap Australian beef, firm domestic chicken prices, a weak yen on imported cost. The same management that printed the number guides Fresh Meats down 18.4% the following year. So the question the dossier turns on is whether FY March 2026 is a plateau the group can hold or a cyclical top the share price has already discounted.
That matters more than usual because the rebound is so concentrated and so leveraged. Fresh Meats grew business profit 80.5% on revenue up 8.1% — operating leverage near 9.9x, which is exactly the kind of swing that runs hard in both directions. Processed Foods, meanwhile, earns 1.35% and is dragged by under-utilised North American plants ; the ballpark earns 19.5% but is small. A consensus that pencils earnings per share at ¥433 against management's own ¥404 is, in effect, betting the spread holds — a bet on Australian cattle costs and a Chinese protein cycle that have disappointed before.
There is a quieter point that reframes the whole case. The dossier was inherited as deep value : the lowest price-to-book in its peer group, a balance sheet finally being returned to shareholders, a cyclical caught at the bottom of its multiple. Read against the certified segment data, most of that has already happened. The ¥30bn buyback landed, 4.9% of the share count was cancelled in April 2026, and the price-to-book re-rated from a 0.95x trough to 1.06x. Sum the parts on normalised profit and equity reconstructs to ¥5,849 — a few percent below the spot, not above it. The cheap entry the inherited thesis was waiting for is largely in the past.
What that leaves is a recovery that is real, well-financed, and mostly priced. The remaining upside is not in the spread ; it is in two things the multiple does not yet pay for. One is whether the ballpark — a record-attendance entertainment and property asset earning 19.5%, buried inside a consolidated food multiple — is ever recognised as a distinct pole. The other is whether Processed, guided to turn from a ¥7.2bn drag toward ¥12bn, actually fixes its overseas plants. Both are options, neither is proven.
The position framing is patient observation, not ownership at this level. Fair value sits within a point or two of the price and the asymmetry is favourable but moderate, roughly 1.6x, with a downside floored near the book by an active buyback. Conviction is moderate. The things worth watching are the Fresh Meats margin and any signal on the ballpark or the buyback ; all are observable on the published calendar.
The cleanest way to read the last decade is as one long cycle with an expensive detour in the middle. NH Foods entered it as a stable integrator — EBIT margins of 4–4.5%, return on capital around 7–8%, a light balance sheet. It then spent ¥82.3bn building the ES CON FIELD ballpark, and it did so at the worst possible moment : the FY March 2023 trough, when the EBIT margin was 1.0%, free cash flow ran to −¥70.9bn and net debt reached 3.72x EBITDA. The recovery since has been genuine — free cash flow back to +¥47.9bn, leverage down to 1.58x, business profit at a cyclical high — but it is recent and it rests on the spread. The shape matters because it makes any valuation anchored on a ten-year average multiple meaningless ; that average is dragged by the depressed years in the middle.
| Inflection | FY 2017Stable integrator | FY 2021COVID & feed | FY 2023Capex trough | FY 2025Deleveraging | FY 2026Spread peak |
|---|---|---|---|---|---|
| Revenue (¥bn) | 1,202.3 | 1,106.4 | 1,259.8 | 1,370.6 | 1,457.4 |
| EBIT (¥bn) | 53.8 | 41.0 | 12.3 | 32.8 | 56.1 |
| EBIT margin | 4.5% | 3.7% | 1.0% | 2.4% | 3.9% |
| Return on capital | 8.2% | 4.9% | 1.2% | 3.2% | 5.4% |
| Return on equity | 9.1% | 7.6% | 3.4% | 4.9% | 6.4% |
| FCF (¥bn) | 25.1 | 23.1 | −70.9 | 41.5 | 47.9 |
| Net debt / EBITDA | 0.50x | 1.61x | 3.72x | 2.21x | 1.58x |
| Net Income (¥bn) | 35.0 | 32.6 | 16.6 | 26.6 | 35.1 |
| EPS reported (¥) | 343.5 | 318.0 | 162.4 | 263.1 | 361.1 |
Source: Data pack 11 June 2026 (FY March close-year ; data pack start-year labels rebased −1). EBIT = operating income ; managerial business profit is sourced only from FY March 2025 (¥42.5bn) and FY March 2026 (¥68.3bn) and runs ~22% above EBIT. Return on capital is NOPAT over net debt plus equity at a 32% normalised tax rate. Net debt is lease-inclusive (IFRS 16). The 2:1 reverse split of March 2018 is reflected in the per-share line.
Three management decisions explain the shape. The North American Processed acquisitions put capital into the lowest-returning part of the group — a segment still earning 1.35% on under-utilised plants — which is growth measured in volume rather than return. The ballpark build committed ¥82.3bn at the cycle trough, turning a defensible strategic asset into a temporary liquidity strain. And the capital discipline arrived late : years of sub-cost-of-capital returns passed under TSE reform pressure before the first decisive gesture, the 4.9% cancellation, came in April 2026. The discipline since is corrective and real, but it is recent, and the same balance sheet that funds today's buyback once funded the over-extension.
The engine only makes sense once you stop looking at the consolidated line and look at the segments, because they are economically different businesses sharing a balance sheet. Fresh Meats earns about 6% on roughly two-thirds of revenue and carries the group. Processed Foods earns 1.4%. Sports & Entertainment — the ballpark — earns 19.5% on 2% of revenue. A single 4.7% group margin is the weighted average of a cyclical spread business, a chronically dilutive one, and a small high-return franchise, which is exactly why a single food multiple is the wrong tool and the valuation has to be built part by part.
Where the money is made is a spread, and that word does a lot of quiet work. Fresh Meats captures the gap between the cost of livestock — domestic chicken, imported Australian beef — and the price of the meat it sells. In FY March 2026 that gap was wide, helped by a favourable cycle and a weak yen, and the segment's profit rose 80.5%. That is spread capture on a good cycle, and it reverses when the input cost catches up, which is precisely what the FY March 2027 guidance encodes : an ¥8bn drag from Australia as cattle costs and logistics rise. The pricing here is not the durable kind. The only real pricing power in the group sits in the SCHAU ESSEN brand, which is sub-scale, and in the ballpark's captive audience, which is small.
The critical cost is therefore the price of protein, and Australian beef in particular — a commodity-plus-currency input with a two-to-three-quarter lag onto the income statement. NH Foods manages it differently from a pure distributor because it owns feedlots in Australia, at Whyalla and Oakey, which give it partial control over the upstream cost the others simply buy. That vertical integration is the real operational moat in the dossier, and it is genuinely two-edged : it captures margin in a good cycle but exposes the segment directly to cattle prices and the yen in a bad one. It does not immunise the spread ; it only softens it.
The cash conversion is solid and is part of what protects the downside, with one caveat worth stating plainly. Free cash flow ran ¥47.9bn in FY March 2026, around 70% of business profit, and the balance sheet is back to 1.58x with a 53.8% equity ratio. But depreciation now exceeds capital expenditure by about ¥11.7bn — the asset base is running off faster than it is being replaced, which flatters the free cash flow ; a normalised capex would lower it. Against the cash sit the things the multiple ignores : the ES CON FIELD land, whose fair value is not disclosed, and a ¥40bn buyback that has not yet started. The book value and that buyback are the real floor under this name, and the ballpark is the one asset the consolidated multiple does not pay for.
This pillar carries the thesis because the entire re-rating runs through it, not through the operations. NH Foods earns its cost of capital and no more ; what moved the price-to-book off its trough was the return of capital, and the sector law is explicit that the book re-rates on a dated restitution catalyst rather than on dormant quality. The programme is now real : a ¥30bn buyback completed, 4.85m shares — 4.9% of the count — cancelled in April 2026, a fresh ¥40bn authorisation worth about 7% of the cap, a 3.0% dividend-on-equity floor and a 40%-plus payout, on an equity ratio of 53.8%. The limit is that most of this is already in the 1.06x book. The open question is whether the buyback survives a guided-down year — which is the test of structural discipline against opportunism at the cash peak.
The moat is the second cardinal because it decides whether the spread is defensible and it is what floors the downside, even though it is narrow. The vertical integration into Australian beef is the real edge — owned feedlots give partial control of the upstream cost a pure distributor carries blind, and it is what makes the bear case a timing disappointment rather than a permanent loss. Around it sit two smaller barriers : the SCHAU ESSEN premium brand, real but sub-scale, and ES CON FIELD, unique and non-replicable but 2% of revenue. The core protein business is a commodity with no pricing power and no switching cost. The moat is genuine, partial, and confined to the cost side of one segment.
Volume is defensive — meat is a staple, beta 0.21–0.47 — but the economics are a cyclical margin, not a stable volume. A demographic ceiling caps domestic growth ; the ballpark adds higher-quality demand (+16% revenue CAGR) but is marginal in size.
Return on capital of 5.4% sits at the cost of capital, return on equity 6.4% against a 10% target. Cash conversion of 70% is real but flattered by capex running below depreciation, and Processed dilutes the group at 1.4%. No structural value creation above the hurdle.
A mixed record — the ballpark timed at the trough, dilutive North American M&A, late restitution — set against a clear recent inflection and honest guidance : the team guides its own engine down even as the cycle favours it. Credibility now rests on fixing Processed.
A median cyclical with improving governance — no pillar of operational excellence, no fatal flaw. Above a value trap such as Morinaga Milk, below a quality compounder such as Nichirei (17/25) or Food & Life (19–20/25). The grade is consistent with the valuation : it earns no premium on the consolidated line, and once the parts are summed there is no discount to claim either. A deep value in resolution rather than a compounder.
Is the FY March 2026 business-profit peak a structural plateau, or a cyclical top already in the price ?
Is the ballpark a distinct value pole, or an accessory ?
The market prices NH Foods on a single consolidated food multiple, with no separate credit for ES CON FIELD. Against that, the segment earns 19.5% with operating profit compounding around 51% over three years on record attendance of 4.66m. But it is ¥5.4bn of profit, 8% of the group, and on a cap-rate it is worth perhaps ¥50–90bn — a real option, not a dominant engine. Its recognition hangs on a disclosure that has not come.
Is the capital discipline structural, or opportunistic at the cash peak ?
The escalation from a ¥30bn buyback to ¥40bn, the 4.9% cancellation and the 3.0% dividend-on-equity floor read like a changed posture. But the timing coincides with the peak of cash generation, which keeps the doubt alive : a programme funded by a cyclical high is not yet proof of through-cycle commitment. This is the lever that floors the downside, so its durability matters more than its size.
At ¥6,057 and ~14x forward earnings, the market is pricing a cyclical of ordinary quality whose balance-sheet catalyst is largely spent. Two things are embedded : a normalised earnings power close to the ¥61bn the company guides for FY March 2027, and a price-to-book that has re-rated from a 0.95x trough to 1.06x on the buyback. The headline EV/EBITDA of ~8x looks cheap, but it sits on a peak EBITDA — the highest of the decade — and compresses three different economies into one number. Valued part by part on normalised profit, the sum reconstructs to ¥5,849, just below the spot. What is not embedded is recognition of the ballpark as a distinct asset or a Processed turnaround. Neither is proven, so neither is priced — which is rational, not a mistake.
The Australian cost stays elevated into FY March 2028 and the spread stays compressed ; Processed fails to turn, with overseas still loss-making ; the ballpark holds at ¥4bn and there is no re-rating. The mechanical sum-of-the-parts would give ¥3,929, but the book at ¥5,704 and the ¥40bn buyback floor the realistic bear at ~¥5,100, or 0.89x book. This is a cyclical trough, reversible, not a permanent destruction of capital.
The spread normalises mid-cycle, group business profit settles near ¥63bn, Processed recovers modestly, the ballpark holds at ¥4.5bn and the buyback runs to about half. The cellular sum of the parts gives ¥5,849 ; triangulated with a 15x normalised P/E and a 1.1x book, the base lands at ¥6,100. The market is broadly right — the fair value does not need a consolidated re-rating, it lands on the spot.
The two un-priced levers fire together. The spread holds as Australia normalises and China recovers, Processed reaches ¥12bn as overseas hits break-even, and the ballpark is recognised as a distinct pole — a tighter 6% cap-rate, a carve-out or REIT signal, worth ~¥90bn — while the buyback runs in full to a 87m share count. The mechanical bull SOTP is ¥7,903 ; the target is ¥7,600, aligned with the top of the sell-side range. The path needs both the operations and the recognition, neither signalled today.
| KPI | Latest value | Status | What it tells us |
|---|---|---|---|
| Fresh Meats segment margin | 5.9% FY2026 | Cardinal | The swing variable. At or above 5.5% through FY March 2027 confirms the plateau ; at or below 4.5% over Q1–Q2 confirms the cyclical top and pulls fair value toward ¥5,100. Guidance implies ~4.8%. |
| ¥40bn buyback execution | 0% at 16 Jun 2026 | Cardinal | The floor and the catalyst test. Deadline 31 March 2027. Holding the buyback and the 3.0% dividend-on-equity through a guided-down year confirms structural discipline ; a withdrawal confirms opportunism. |
| ES CON FIELD / S&E operating profit | ¥5.4bn FY2026 | Trigger | 19.5% margin, +61.9% on record 4.66m attendance, guided down to ¥4bn. A disclosed land fair value (IAS 40) or OP above ¥7bn forces recognition of a distinct pole — the main un-priced upside. |
| Processed Foods margin | 1.35% FY2026 | Watch | Guided to turn toward ¥12bn from ¥7.2bn. A margin at or above 2.5% sustained over two to three quarters validates the turnaround ; below 1.8% confirms the chronic drag from overseas plants. |
| Price-to-book | 1.06x spot | Reference | The lowest of the decade, re-rated from a 0.95x trough on the buyback. Above ~1.4x without fundamental improvement reads expensive ; below 0.95x would be a de-rating despite the catalyst. |
| Shareholder yield (forward) | ~10% potential | Reference | FCF yield 8.4%, FY2026 shareholder yield 7.9% ; forward ~10% on a ¥180 dividend plus the ¥40bn buyback — conditional on execution. This is the real downside support, not the 2.97% dividend yield. |
| North America goodwill | ¥39.1bn | Reference | The permanent-loss route. An impairment, or value-destructive sub-cost-of-capital M&A, would break the timing-disappointment reading and force a full re-underwriting toward ~¥3,900. |
The case turns positive if the spread proves it is a level rather than a top, or the dormant assets are recognised. A Fresh Meats business-profit margin holding at or above 5.5% through FY March 2027, a disclosed ES CON FIELD land value or a carve-out signal, or the ¥40bn buyback running in full while the dividend-on-equity holds, would move the dossier from watchlist to long and open the bull path. Each is observable ; none is signalled today.
The case turns negative if the narrow engine stalls. A Fresh Meats margin at or below 4.5% over two consecutive prints would confirm the cyclical top and reset fair value toward ¥5,100. The book at ¥5,704 and the active buyback hold that floor, so the bear is a reversible timing disappointment — provided the buyback is not withdrawn as profit falls, which is the one move that would remove the support.
The allocation risk is the one to watch most carefully, because the company has made it before. A repeat of the North American over-extension — value-destructive M&A below the cost of capital, or a goodwill impairment on the existing ¥39.1bn — would burn the balance sheet that currently floors the name and force a complete re-underwriting toward the mechanical trough near ¥3,900. Currently not signalled.
The information provided on this website is for informational and educational purposes only and should not be construed as financial, investment, legal, or tax advice. All content reflects the personal opinions, interpretations, and analyses of the author at the time of writing and is subject to change without notice. Nothing contained herein constitutes, or should be interpreted as, a recommendation, solicitation, or offer to buy or sell any securities, financial instruments, or other investment products. The author is not a licensed financial advisor, broker, or investment professional. Any references to specific assets, markets, or strategies are illustrative in nature and do not constitute personalized investment advice. Investing in financial markets involves risk, including the potential loss of capital. Past performance is not indicative of future results. Readers are solely responsible for their own investment decisions and should conduct their own independent research and due diligence before making any financial commitments. You are strongly encouraged to consult with a qualified financial advisor, legal professional, or other relevant specialist before making any investment or financial decisions. By accessing and using this blog, you agree that the author shall not be held liable for any direct or indirect losses, damages, or consequences arising from the use of, or reliance on, the information presented herein. All content is provided "as is" without any warranties of completeness, accuracy, or reliability.